CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 5, 2022 · earnings

NKTR earnings: a positive outcome, +10.4%

On August 5, 2022, Nektar Therapeutics reached its earnings. The result was a positive outcome, and the stock moved +10.4% in the window around the event.

The move

$66.30
1d before
$73.20
Event day
$73.20
1d after
$72.75
5d after

Pre-catalyst setup

+3.3%
30-day run-up
7874%
30-day volatility
0.6×
volume spike